BRIEF-Ampio Updates Regulatory, Clinical And NYSE Activities

* BEGUN PRELIMINARY DISCUSSIONS WITH FDA ON DETAILS OF BLA SUBMISSION PROCESS FOR AMPION
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.